NUCB2 and neoplasm: Consistent with these findings, in the GSE26712 validation set, the expression of BANF1, CDK2AP2, DDT, LRIG1, MRPL4, and S100A13 was significantly upregulated in tumor samples, and the expression of EPS8, NUCB2, PAF1, PMP22, RABGAP1L, and USO1 was higher in control samples (p < 0.05) (Figure 9B).